Friday, June 13, 2025 | 12:48 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

AstraZeneca, Russia's Sputnik V developer to sign cooperation memorandum

President Vladimir Putin hailed British drugmaker AstraZeneca's decision to test combining its own experimental Covid-19 vaccine with Russia's Sputnik V shot

AstraZeneca
premium

Clinical trials, still under way, have shown Sputnik has an efficacy of over 90 per cent

Reuters
Britain’s AstraZeneca and Russia's Gamaleya Institute, which developed the Sputnik V vaccine, will sign a memorandum of intent on cooperation on Monday, the Kremlin said.
 
Russia’s RDIF sovereign wealth fund said this month AstraZeneca would start clinical trials to test a combination of its experimental Covid-19 vaccine with the Sputnik V shot to see if this can boost the efficacy of the British drugmaker's vaccine.
 
President Vladimir Putin hailed British drugmaker AstraZeneca's decision to test combining its own experimental Covid-19 vaccine with Russia's Sputnik V shot.
 
Clinical trials, still under way, have shown Sputnik has an efficacy